MedTrace Logo

Is the Direct Inferior Alveolar Nerve Block Required for Third Lower Molar Extraction?

NCT03443726 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2020-03-31

No results posted yet for this study

Summary

This study is a Randomized Controlled Trial (RCT) which objective is to compare the effectiveness, efficacy and complication associated to an infiltrative anesthetic technique for the removal of lower third molars comparing it to the standard inferior alveolar nerve block using 4% articaine 1:100.000 epinephrine.

Conditions

  • Tooth Extraction
  • Dental Anesthesia

Interventions

PROCEDURE

Nerve block technique

Inferior alveolar nerve block with 1.8 cc of 4% articaine 1:100.000 epinephrine and 1.8 cc of the same anesthetic for the buccal nerve for third molar extraction.

PROCEDURE

Infiltrative technique

Infiltrative anesthesia buccally between first and second mandibular molar with 3.6 cc of 4% articaine 1:100.000 epinephrine and 0.6 cc lingually to the third molar using the same anesthetic solution.

DRUG

4% articaine 1:100.000 epinephrine

Articaine in a 4% solution with epinephrine 1:100,000 (Artinibsa; Inibsa Dental, Lliçà de Vall, Spain)

PROCEDURE

Third molar extraction

Third molar extraction under local anesthesia.

Sponsors & Collaborators

  • University of Barcelona

    lead OTHER

Principal Investigators

  • Rui Figueiredo, DDS, MS, PhD · University of Barcelona

  • Eduard Valmaseda-Castellon, DDS, MS. PhD · University of Barcelona

  • Stavros J Sofos, DDS, MS. · University of Barcelona, Nova Southeastern University.

  • Leonardo Berini-Aytes, MD, DDS, PhD · University of Barcelona

  • Octavi Camps-Font, DDS, MS · University of Barcelona

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-10
Primary Completion
2018-11-10
Completion
2018-12-20

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03443726 on ClinicalTrials.gov